Showing 1 - 20 results of 173,575 for search '(( 16 we decrease ) OR ((( 10 ((mg decrease) OR (_ decrease)) ) OR ( _ wt decrease ))))', query time: 0.63s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Ectopic lesions are decreased in PUGKO mice compared to controls. by Jan Sunde (8837384)

    Published 2024
    “…This was measured by comparing the counted IHC FOXA2 stained uterine glands of microscopic images in 4 high power fields (HPF) of 40 magnification in PUGKO tdT (D) vs WT (C) Scale Bar = 100 μm. PG treatment in PUGKO mice decreases the expression of FOXA2 almost 33 times compared to the non-PG TX mice. …”
  6. 6

    Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

    Published 2025
    “…Their median baseline variabilities of respiratory rate and tidal volume were 0.19 (IQR: 0.16–0.25) and 0.23 (0.19–0.34), respectively. While mean respiratory rate was not affected, midazolam resulted in a significant decrease in both VRR (ß = −0.071, 95% CI: −0.120 to −0.021) and VTV (ß = −0.117, 95% CI: −0.170 to −0.062). …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…<b>B.</b> Introduction of WT1 siRNA leads to decrease total cell number using trypan blue to assess cell viability compared to control siRNA, p<0.01 (**) using two-sided, unpaired student’s t-tests. …”
  19. 19

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
  20. 20